Close Menu

NEW YORK (GenomeWeb) – Verge Genomics, a startup developing machine learning technologies to apply genomics to drug discovery in neuroscience, said today that it has closed a $32 million Series A funding round.

Silicon Valley investment firm DFJ led the round, with participation from the WuXi AppTec's Corporate Venture Fund, the ALS Investment Fund, Agent Capital, and the OS Fund.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.